Become A Research Partner

National Brain Tumor Society funds only the most promising research poised to deliver results. Our funded research has contributed to the establishment of many of what are now the top adult and pediatric brain tumor research labs across the country, as well as advances in understanding brain tumor makeup and what could drive more effective treatments.

By partnering with us and supporting our strategic initiatives, you can help advance the understanding of brain tumors, improve the availability of new treatments, and drive the discovery of a cure. Learn more about the initiatives that you can contribute to directly.

Defeat GBM

Glioblastoma multiforme (GBM) is a highly aggressive, complex, and devastating form of brain cancer, effecting hundreds of people each day. We believe it is our duty to accelerate progress against this disease so we launched the Defeat GBM Research Collaborative in 2013 with the intent to double the 5 year survival rate of GBM patients. This comes at a time when collaboration is becoming the norm and the abundance of genomic data is accelerating diagnostic, prognostic, and therapeutic progress.

Oligo Research Fund

Oligodendroglioma (oligo) is a relatively rare brain tumor representing about 6% of gliomas, with a diagnosis rate of about 1,150 patients a year in the U.S. alone. Critical research is required to deliver oligo patients new therapies that are more durable and extend their lives. In order to make effective, targeted therapies a reality it is essential to identify and understand the molecular drivers of the tumor’s genesis and maintenance, as well as resistance.

Pediatric Initiatives

Our new pediatric initiative, Project Impact, will leverage increases in knowledge gained from earlier funded research efforts, and develop a program that can address critical barriers to progress within the drug discovery and development pipeline through an integrated approach to advance research toward new treatments for pediatric brain tumor patients.

Community Research

The Community Research Fund allows contributors to pool donations to support research on a specific type of tumor. This program leverages a team of highly experienced, nationally-recognized scientific experts, working with National Brain Tumor Society staff, to determine the best investment strategy for each fund.


From the Blog

  • July 24, 2015

    Update on the Oligodendroglioma Research Fund

    nci-vol-3697-300

    In 2011, the National Brain Tumor Society launched our Community Research Fund (CRF) model. The goal of the model was to allow groups of donors with a common interest to pool their funding together and fund research in an area that wa

    Read More

  • July 23, 2015

    Precision Medicine Conference Highlights

    precisjen-e1437675013280

    Precision medicine, also referred to as personalized or individualized medicine, is defined on Wikipedia as “a medical model that proposes the customization of healthcare—with medical decisions, practices, and/or pro

    Read More

  • July 15, 2015

    National Brain Tumor Society Appoints David Arons Interim Chief Executive Officer

    National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, has today appointed David Arons, JD, as interim Chief Executive Officer. Mr. Arons has served as Chief Public Policy and Advocacy Officer at the National Brain Tumor Society for the past four years. “We are excited to […]

    Read More

More from the blog